DataMeds AI Shares Surge Over 25% on Launch of GLP-1 Health App

DataMeds AI, Inc. (MEDS) shares climbed more than 25% on September 28, 2026, after the healthcare company and Tollo Health, LLC announced the launch of the Health Lives Here mobile application. The app initially targets users of GLP-1 receptor agonists, a class of diabetes and weight-loss drugs. Tollo Health commercializes proprietary medical foods and dietary supplements. The announcement drove the sharp intraday gain in MEDS stock. No financial terms or revenue projections for the app were disclosed.